What should I do if I am resistant to brigatinib?

Brigatinib (Brigatinib) is an important targeted therapy drug that is widely used in the treatment of non-small cell lung cancer, especially for ALK-positive patients. It controls the development of cancer by specifically inhibiting the growth signals of tumor cells. However, as treatment progresses, some patients may develop drug resistance, that is, the inhibitory effect of the drug on cancer cells weakens or fails.

When resistance to brigatinib occurs, patients and doctors need to face this challenge together. First of all, drug resistance does not mean treatment failure, but it indicates that we need to adjust treatment strategies. The doctor will conduct a comprehensive assessment based on the patient's specific situation, including the rate of disease progression, the patient's overall health, and previous treatment effects.

Next, doctors may consider substituting or combining other targeted drugs. For example, rexitinib and crizotinib are common alternatives that inhibit the growth of cancer cells through different mechanisms and may still be effective against drug-resistant tumors. In addition, some new drugs or treatments are constantly emerging, providing patients with more choices.

In addition to drug treatment, the active participation of the patient himself is also crucial. Maintain a positive attitude, cooperate with the doctor's treatment recommendations, and pay attention to nutrition and exercise to improve your own immunity, which will help you better deal with drug resistance problems.

In addition, research on drug resistance is also a hot topic in the current medical field. Scientists are working to uncover the mechanisms of drug resistance and explore new treatment strategies to overcome this problem. Therefore, even if faced with drug resistance, patients do not need to panic too much. With the deepening of scientific research, more effective solutions may emerge in the future.

In conclusion, brigatinib resistance is a challenge in the treatment of lung cancer, but it is not insurmountable. Through the professional guidance of doctors, the active participation of patients, and the continuous advancement of scientific research, we can hope to find better ways to deal with drug resistance and help patients continue their journey to fight cancer.